标题
Biology of Bone Metastases
作者
关键词
-
出版物
Cancer Control
Volume 19, Issue 2, Pages 92-101
出版商
SAGE Publications
发表日期
2017-08-30
DOI
10.1177/107327481201900203
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer
- (2011) R. Coleman et al. BREAST CANCER RESEARCH AND TREATMENT
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial
- (2010) Anders Bonde Jensen et al. Clinical Breast Cancer
- Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases
- (2010) O. Filleul et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Implications of Bone Metastases and the Benefits of Bone-Targeted Therapy
- (2010) Allan Lipton SEMINARS IN ONCOLOGY
- Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
- (2009) M. Fulciniti et al. BLOOD
- Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: Recommendations for prevention and treatment
- (2009) T. Fehm et al. BREAST
- Bisphosphonates in the Prevention of Disease Recurrence: Current Results and Ongoing Trials
- (2009) M. Gnant CURRENT CANCER DRUG TARGETS
- Efficacy of ibandronate for the treatment of skeletal events in patients with metastatic breast cancer
- (2009) P. HERAS et al. EUROPEAN JOURNAL OF CANCER CARE
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
- (2009) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Bisphosphonates and Time to Osteonecrosis Development
- (2009) P. K. Palaska et al. ONCOLOGIST
- Molecular mechanisms and treatment of bone metastasis
- (2008) Gregory A. Clines et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma
- (2008) I Breitkreutz et al. LEUKEMIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started